약 50%의 암 환자에게 치료적 또는 완화적 목적으로 방사선 치료가 필요하다고 추정됩니다.
Radiotherapy (RT) is an essential component of evidence based multidisciplinary cancer care.
It is estimated that RT is indicated for approximately 50% of patients with cancer for either curative or palliative treatment.
1. Beckett M, Goethals L, Kraus RD, Denysenko K, Barone Mussalem Gentiles MF, Pynda Y, Abdel-Wahab M. Proximity to Radiotherapy Center, Population, Average Income, and Health Insurance Status as Predictors of Cancer Mortality at the County Level in the United States. JCO Glob Oncol. 2023 Sep;9:e2300130.
2. Hanna TP, Shafiq J, Delaney GP, et al: The population benefit of evidence-based radiotherapy: 5-year local control and overall survival benefits. Radiother Oncol 126:191-97, 2018
3. Borras JM, Lievens Y, Dunscombe P, Coffey M, Malicki J, Corral J, Gasparotto C, Defourny N, Barton M, Verhoeven R, van Eycken L, Primic-Zakelj M, Trojanowski M, Strojan P, Grau C. The optimal utilization proportion of external beam radiotherapy in European countries: An ESTRO-HERO analysis. Radiother Oncol. 2015 Jul;116(1):38-44.
4. Delaney G, Jacob S, Featherstone C, et al: The role of radiotherapy in cancer treatment: Estimating optimal utilization from a review of evidence-based clinical guidelines. Cancer 104:1129-1137,2005
